Common questions about Entocort CR (FAQ)
Q: How quickly does Entocort CR usually start working?
Regulatory documents do not specify an exact timeframe for initial symptom relief. However, studies for active disease are typically conducted over an 8-week course. The active ingredient, budesonide, works by changing how certain genes are expressed, an anti-inflammatory process that can take hours or days to begin generating a clinical effect.
Q: What does it mean that Entocort CR is 'locally acting'?
It means the medicine is formulated to deliver most of the active ingredient directly to the ileum and ascending colon (the lower bowel) where the inflammation occurs. Because the medicine is highly processed by the liver, only a small amount enters the bloodstream. This results in low systemic exposure, meaning less medicine reaches the rest of your body.
Q: What kind of monitoring is typically needed when taking Entocort CR?
Since Entocort CR is a glucocorticosteroid, official warnings advise monitoring for signs of adrenal axis suppression (where the body stops making its own steroids) or hypercorticism (signs of too much steroid in the body). Patients may need to have blood tests from time to time for general monitoring purposes, and those with pre-existing conditions like diabetes may require specific follow-up.
Q: What medical conditions would prevent someone from being able to use Entocort CR?
Official information states the medicine is contraindicated if you have a known severe allergy to budesonide or any other ingredient in the capsule. Warnings also advise avoiding use in patients who have severe hepatic impairment (severe liver disease) or certain systemic fungal infections.
Q: Are there any specific organs that Entocort CR is primarily focused on treating?
Yes, the medicine is specifically indicated for treating active inflammation in the ileum and/or the ascending colon. This targeted delivery is an important feature of the medicine’s controlled-release formulation.
Q: What are the major known drug interactions listed in regulatory documents for Entocort CR?
The most significant interactions involve medicines that are strong CYP3A4 inhibitors. This is a type of enzyme inhibitor that can substantially increase the level of budesonide in the body, potentially leading to more systemic side effects. Examples of strong inhibitors mentioned in official documents include certain antifungal medications and some HIV medications.
Q: Is it normal to feel tired when starting Entocort CR?
Yes, official clinical trial data lists fatigue as a common adverse reaction, which means it occurred in 5% or more of adult patients taking the medicine during the studies.
Q: Is Entocort CR known to cause weight gain?
Official information lists weight increase as an adverse reaction observed in clinical studies. This is linked to the general effects of glucocorticosteroids, which can include signs of hypercorticism (sometimes called Cushing’s syndrome), such as changes in fat distribution.
Q: Can Entocort CR affect sleep patterns?
While the medicine is generally well-tolerated, psychiatric disorders, including mood swings, have been noted in postmarketing reports. As a glucocorticosteroid, its effects on the central nervous system may include changes that could affect sleep, although insomnia is not listed as a common reaction.
Q: Is it safe to drink alcohol in moderation while taking Entocort CR?
Official drug information does not specifically list alcohol as an interaction. However, because alcohol may increase the risk of certain side effects, such as dizziness and tiredness, regulatory information advises caution.
Q: Do studies suggest Entocort CR is safe for long-term use?
Regulatory documents define the typical maximum treatment duration for active disease as up to 8 weeks, with maintenance use limited to about 3 months. Official warnings note that systemic effects, such as adrenal suppression, may occur when glucocorticosteroids are used chronically (for long, continuous periods).
Q: Can Entocort CR cause or worsen mood changes?
Yes, official documents note that psychiatric disorders, including mood swings, have been reported. Warnings also advise caution in patients who have prior or existing mental health problems, as glucocorticosteroids may affect them.
Q: Is Entocort CR approved for use in children?
Yes, according to the official label, this medicine is approved for use in pediatric patients aged 8 to 17 years who weigh more than 25 kg. It is used to treat mild to moderate active Crohn’s disease in this population.
Q: Can Entocort CR be taken during pregnancy?
Official documents state that there are no adequate studies on pregnant women. The medicine should only be used during pregnancy if the expected benefit to the mother is believed to be greater than any potential risk to the fetus.
Q: What if I take other prescription medications; do they interact with Entocort CR?
Many prescription medications can interact with Entocort CR, particularly those that are strong CYP3A4 inhibitors. The product insert also mentions that certain drugs containing oestrogens (like some oral contraceptives) and the cholesterol-reducing drug cholestyramine may also interact.
Q: Does Entocort CR impact bone density over time?
Official warnings advise caution for patients who have or are at risk of osteoporosis (brittle bones). As a glucocorticosteroid, its use may potentially affect bone health, and this is a general factor that doctors consider when prescribing the medicine.
Q: Is there a generic version of Entocort CR available?
Yes, the active ingredient, budesonide, is available in generic delayed-release capsule form, which the regulatory body (FDA) states is bioequivalent to the branded product.
Q: How does Entocort CR affect the immune system?
Like other corticosteroids, the medicine can cause immunosuppression, meaning it reduces your body’s natural ability to fight off infections. Because of this, patients may be more susceptible to new infections and serious viral infections like chickenpox can be more severe.
Q: What is the difference between Entocort CR capsules and the brand name Budesonide?
Budesonide is the active ingredient and the generic name for the medicine. Entocort CR is the brand name given to the specific controlled-release formulation of budesonide capsules.
Q: Does Entocort CR require a special diet?
The only mandatory dietary restriction noted in regulatory documents is the avoidance of grapefruit and grapefruit juice for the duration of therapy. Grapefruit can significantly increase the amount of medicine that enters your bloodstream, leading to higher risks of systemic side effects.
Q: Can Entocort CR be taken with antacids?
Official patient information advises that you should not take antacids or indigestion remedies during the two hours before and the two hours after taking this medicine. This is because antacids may interfere with the controlled-release mechanism of the capsule.
Q: Is Entocort CR known to cause stomach upset?
Official clinical trial data indicates that common gastrointestinal side effects can include nausea (upset stomach), dyspepsia (indigestion), and stomach pain (abdominal pain). These occurred in 5% or more of adult patients taking the medicine.
Q: How long does it take for the effects of Entocort CR to fully wear off after stopping treatment?
The medicine is quickly metabolized by the liver, but the full clearance of the active ingredient from the body takes several half-lives. The body naturally clears the medicine over a period of time after the last dose is taken.
Q: Are there restrictions on getting vaccinations while using Entocort CR?
Yes, due to the immunosuppressive effect of the medicine, regulatory warnings advise patients to avoid receiving live attenuated vaccines while undergoing treatment.
Q: Is Entocort CR used for conditions that affect the stomach?
The medicine is specifically indicated for treating the ileum and ascending colon (the lower parts of the intestines). It is not indicated for treating conditions that directly affect the stomach.
Q: Does Entocort CR interact with birth control pills?
Yes, official documents note that medicines containing oestrogen, such as some oral contraceptives, may interact. This interaction can potentially increase the blood level of budesonide, which may increase the risk of side effects.
Q: What research supports the use of Entocort CR for the colon?
Regulatory approval is supported by multiple randomized, double-blind, placebo-controlled trials. These studies demonstrate the medicine's effectiveness for the induction of remission in mild to moderate Crohn’s disease, specifically when it involves the ileum and/or ascending colon.
Q: How is Entocort CR different from oral Prednisone?
Entocort CR has a low systemic bioavailability, meaning much less of the drug reaches the rest of the body compared to systemic steroids like Prednisone. Studies have examined the occurrence of certain steroid-related side effects and found that they are generally reported with lower frequency for Entocort CR compared to systemic steroids like Prednisone, which is attributed to its localized action.
Q: Are patients on Entocort CR more susceptible to certain infections?
Yes, because the medicine can cause a reduction in immune response (immunosuppression), patients may be more susceptible to infections. Official warnings also note that certain viral infections, like measles and chickenpox, can take a more severe course.
Q: Does Entocort CR cause problems with eyesight?
Official warnings advise caution for patients who have or are at risk of glaucoma or cataracts. Postmarketing experience has also reported cases of benign intracranial hypertension, which is a condition that can affect vision.
Q: Is there an age limit for starting Entocort CR?
The medicine is indicated for use in pediatric patients aged 8 years and older who weigh more than 25 kg. Use outside of this age range is not covered by the official label.
Q: What is the typical timeframe before a doctor might evaluate the effectiveness of Entocort CR?
The initial treatment course for active disease (induction of remission) is typically for a period of up to 8 weeks. This is the timeframe used in the main regulatory studies to evaluate the medicine's effectiveness in controlling symptoms.
Q: Does Entocort CR affect blood sugar levels?
Yes, official warnings advise caution in patients with diabetes mellitus (high blood sugar) or with a family history of diabetes. Glucocorticosteroids, in general, may have unwanted effects on blood glucose control.
Q: Are there any specific requirements for laboratory tests while on Entocort CR?
Official patient information notes that patients may need to have blood tests from time to time for monitoring purposes. The specific tests and frequency are determined by the treating doctor based on the patient's individual health status.
Q: Does Entocort CR affect fertility?
The product information states that animal studies showed no effect on fertility or reproductive function. There is no information available on the effect on human fertility from regulatory sources.
Q: What is the general classification of Entocort CR as a medicine?
It is generally classified as a glucocorticosteroid indicated for the treatment of mild to moderate active Crohn’s disease and for the maintenance of clinical remission.
Q: Are there warnings about driving or operating machinery while taking Entocort CR?
The official patient information states that the medicine is not likely to affect a person’s ability to drive or use any machines. However, individual side effects, such as dizziness, should be considered.
Q: Is Entocort CR used to prevent flares or to treat active ones?
According to the official label, the medicine is approved for both purposes: the treatment of mild to moderate active Crohn’s disease (flares) and the maintenance of clinical remission (helping to prevent symptoms from returning).
